Switching Anti–Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
What do we know about anti–vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration (AMD)? Briefly, I think we know that pegaptanib is safe, but compared with newer…